Sun Pharma to Invest Upto USD 15 Million for 5 Percent Stake in Pharmazz
Sun Pharma described the investment as strategic, noting it will gain exclusive rights to market and distribute Pharmazz’s drug, Sovateltide, in certain emerging markets.
Sovateltide | 17/08/2024 | By Aishwarya | 195
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy